Page last updated: 2024-12-09
1-tetradecyl-3-methylimidazolium
## 1-Tetradecyl-3-methylimidazolium: A Powerful Tool for Research
1-Tetradecyl-3-methylimidazolium, often abbreviated as **[C14mim]+**, is a **cationic surfactant** belonging to the family of **imidazolium-based ionic liquids**. Its chemical structure comprises a positively charged imidazolium ring with a long alkyl chain (tetradecyl, C14) attached to one nitrogen atom and a methyl group (CH3) attached to the other nitrogen atom.
**Why is it important for research?**
1-Tetradecyl-3-methylimidazolium has gained significant attention in various scientific fields due to its unique properties and potential applications, particularly in:
* **Ionic Liquids:** [C14mim]+ is a key component in the development of **room-temperature ionic liquids** (RTILs). These are salts that are liquid at room temperature and exhibit remarkable properties like low volatility, high thermal stability, and excellent ionic conductivity. They have immense potential in various applications, including:
* **Green Chemistry:** Replacing traditional organic solvents in chemical processes to reduce environmental impact.
* **Electrochemistry:** Serving as electrolytes in batteries, fuel cells, and supercapacitors.
* **Catalysis:** Acting as solvents and catalysts in various chemical reactions.
* **Surfactants:** The long alkyl chain of [C14mim]+ makes it a potent surfactant, capable of reducing surface tension and forming micelles in aqueous solutions. These properties are useful for applications in:
* **Biotechnology:** Enhancing the solubility and delivery of drugs and other bioactive compounds.
* **Materials Science:** Creating new materials with specific properties, such as nanoparticles and polymers.
* **Biomedicine:** The amphiphilic nature of [C14mim]+ allows it to interact with cell membranes and influence biological processes. Research is ongoing to explore its potential for:
* **Antimicrobial activity:** Fighting bacterial and fungal infections.
* **Drug delivery:** Delivering therapeutic agents to target cells.
* **Bioimaging:** Visualizing cellular processes.
**Ongoing Research:**
Researchers continue to explore the diverse applications of 1-tetradecyl-3-methylimidazolium in various fields. Current research focuses on:
* **Synthesis of new ionic liquids:** Designing and synthesizing ionic liquids with tailored properties for specific applications.
* **Understanding the mechanism of action:** Elucidating how [C14mim]+ interacts with different systems and influences their behavior.
* **Developing new applications:** Finding new ways to utilize [C14mim]+ in areas like energy storage, environmental remediation, and biomedicine.
**In conclusion,** 1-Tetradecyl-3-methylimidazolium is a versatile and promising compound that holds significant potential in various research areas. Its unique properties and potential applications make it an essential tool for scientists exploring new frontiers in chemistry, materials science, and biotechnology.
Cross-References
ID Source | ID |
PubMed CID | 2734230 |
CHEMBL ID | 3306830 |
SCHEMBL ID | 413428 |
MeSH ID | M0511808 |
Synonyms (8)
Synonym |
1-methyl-3-tetradecyl-imidazol-3-ium |
1h-imidazolium, 1-methyl-3-tetradecyl- |
1-methyl-3-tetradecylimidazol-1-ium |
SCHEMBL413428 |
1-tetradecyl-3-methylimidazolium |
CHEMBL3306830 |
DTXSID50861441 |
3-methyl-1-tetradecyl-1h-imidazol-3-ium |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.26
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.26 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 5.21 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |